Navigation Links
Vivo Ventures Expands Team with the Addition of James Huang as an Executive in Residence
Date:10/24/2007

ams.

Prior to Tularik, Mr. Huang was product director of Avandia and diabetes at SmithKline Beecham PLC (now GlaxoSmithKline) where he launched Avandia (rosiglitazone maleate), which achieved over $2 billion in U.S. sales last year. In addition, he held positions in New Product Development and Worldwide Business Development, negotiating and closing in-licensing agreements for compounds, and managing technology collaborations and corporate development acquisitions.

Mr. Huang also held various positions in Bristol-Myers Squibb's Worldwide Strategic Product Planning, Managed Care and Sales and Marketing organizations, and research and development positions at Alza Corporation (now a Johnson & Johnson company).

He received an M.B.A. from Stanford Graduate School of Business and earned a B.S. degree in Chemical Engineering at the University of California, Berkeley.

About Vivo Ventures

Vivo Ventures is a venture capital firm focused on the life sciences formed in 1996 with over $650M under management. With over 90 years of scientific and operational expertise in biotechnology, Vivo helps its portfolio companies develop corporate strategy, arrange licensing agreements and strategic alliances, recruit key management personnel, and acquire new products and technology to accelerate growth. Its current portfolio includes more than 60 private and public biotechnology companies in the areas of biopharmaceuticals, specialty pharmaceuticals, and medical devices. For more information, visit http://www.vivoventures.com.


'/>"/>
SOURCE Vivo Ventures
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Tech companies get commerce loans for new ventures
2. Conference will focus on financing of early-stage ventures
3. Badger Ventures plans to fund IT; partisan stem-cell battle; BadgerNet draws fire
4. New Madison VC firm Badger Ventures looks for next big IT entrepreneurs
5. WARF expands license agreement with Advanced Cell Technology
6. Verizon expands broadband service in Wisconsin
7. Bandwidth provider expands in Milwaukee
8. Wisconsins biodiesel network expands
9. Quad/Graphics expands reach in western states
10. University of South Florida expands GE Healthcare relationship
11. Metavante expands healthcare payments division
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... 2015   Tocagen Inc. , a clinical-stage ... Tocagen,s ongoing investigational studies were presented at the 11 ... Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons ... in Washington, D.C. In ... with FDA and continues to advance towards initiation ...
(Date:5/4/2015)... Marianjoy Rehabilitation Hospital ... and hand impairments by acquiring the Armeo®Spring arm ... network site. , Secured through grant support of ... treatment option for patients with upper extremity weakness ... one of just four Illinois providers offering treatment ...
(Date:5/1/2015)... May 1, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... announced that it has priced an underwritten registered offering ... price of $9.00 per share, and granted the underwriters ... to an additional 585,000 shares of its common stock. ... million.  The offering is expected to close on May 6, ...
(Date:5/1/2015)... , May 1, 2015 A ... for antithrombotic drugs will reach $22.4bn in 2019. That ... World Industry and Market Prospects 2015-2025 , ... that investigation is to provide forecasts and qualitative analyses ... information publisher and consultancy in London, UK ...
Breaking Biology Technology:Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 2Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 3Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 4Tocagen Presents Updated Interim Survival Data from Ongoing Clinical Studies at American Association of Neurological Surgeons (AANS)/Congress of Neurological Surgeons (CNS) Section on Tumors 5Marianjoy Acquires Armeo®Spring Arm and Hand Rehabilitation Exoskeleton at Oakbrook Terrace Facility 2BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering 2BioAmber Inc. Announces Pricing Of $35.1 Million Registered Offering 3Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 2Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 3Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 4Antithrombotic Drugs: World Industry and Market Prospects 2015-2025 5
... Leaders in probiotics and artificial sweeteners partner ... promises to bring innovation to baking aisleINDIANAPOLIS, ... . a Cleveland-based manufacturer of the patented ... partnership with Heartland Sweeteners , an ...
... Holdings Inc.,(OTC Bulletin Board: CLXS), a leading developer ... the launch of the world,s first,CTSA Experts Platform ... and,their more than 60,000 life science researchers. The ... winners of the Clinical Translational Science,Awards (CTSA,s) from ...
... concerted, nationwide effort to,encourage and strengthen collaboration between ... a powerful team for improved patient safety,-- the ... Patient,Compact during Patient Safety Awareness Week, March 8-14, ... http://www.newscom.com/cgi-bin/prnh/20080307/AQF053LOGO ) , The ...
Cached Biology Technology:Ganeden Biotech and Heartland Sweeteners to Produce Probiotic Sweetener 2Ganeden Biotech and Heartland Sweeteners to Produce Probiotic Sweetener 3Collexis Connects the NIH Clinical and Translational Science Award Programs with CTSA Expert Platform 2Collexis Connects the NIH Clinical and Translational Science Award Programs with CTSA Expert Platform 3NPSF Issues New Universal Patient Compact During Patient Safety Awareness Week 2NPSF Issues New Universal Patient Compact During Patient Safety Awareness Week 3
(Date:4/6/2015)... 6, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, ... 62/143028 for MINIATURE, MULTI-PURPOSE ANTENNA METHOD AND ... NXT-ID introduces a new revolutionary method and ... the use of miniature antenna modules for multiple ...
(Date:4/2/2015)... 2, 2015 Fingerprint Cards (FPC) ... FPC1025 from the distributor World Peace Industrial Group (WPI), ... 2015 although the major part of the shipments will ... used by smartphone manufacturers in China ... in the communicated revenue guidance of + 1 000 MSEK ...
(Date:3/31/2015)... , March 31, 2015   Guidepoint , a ... of the Post-Surgical Pain Management TRACKER, part of the ... usage trends in the medical device and therapeutics markets. ... data including treatment volumes, market share, and adoption rates ... associated with joint surgery. The Post-Surgical Pain ...
Breaking Biology News(10 mins):NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 2NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 3NXT-ID Patents Miniature, Low Power Wireless Magnetic Stripe 4Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 110 Million 2Guidepoint Launches Post-Surgical Pain Management TRACKER 2Guidepoint Launches Post-Surgical Pain Management TRACKER 3
... University of Delaware have made a significant advance in the ... small RNAs in the plant Arabidopsis than previously had been ... of Science magazine. , The research was conducted over the ... from the laboratories headed by Pamela J. Green, Crawford H. ...
... molecular anchor that allows bacteria to invade the nervous system ... meningitis, a University of California, San Diego (UCSD) School of ... anchoring ability, researchers may be able to find a way ... central nervous system and a major cause of childhood death ...
... Research have successfully demonstrated that a theoretical--and controversial--technique ... at least in mice. , The ... researchers first create genetically altered embryos that are ... extract stem cells from these embryos. Because the ...
Cached Biology News:Delaware scientists make significant advance in study of small RNAs 2Delaware scientists make significant advance in study of small RNAs 3Researchers identify molecular anchor that allows bacterial invasion of central nervous system 2Researchers identify molecular anchor that allows bacterial invasion of central nervous system 3Researchers offer proof-of-concept for Altered Nuclear Transfer 2Researchers offer proof-of-concept for Altered Nuclear Transfer 3
Desmosomal Protein Immunogen: Full length, native protein purified from human epidermal keratins. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Mouse monoclonal [SPM217] to Secretory Component Glycoprotein ( Abpromise for all tested applications)....
Mouse monoclonal [3G8] to MDMA ( Abpromise for all tested applications)....
Shh Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Biology Products: